| Clear Cell Renal Cell Carcinoma studied in …STUDIED_INderived200 of 247show all (up to 200) |
|---|
| → studied in | NCT07011719Phase 3 · recruiting Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07671417early Phase 1 · recruiting Imaging Study in Metastatic Clear Cell RCC. · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07770802Phase 1 · recruiting Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594106Phase 1/Phase 2 · recruiting REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07748988Phase 1 · recruiting Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07840001Phase 2 · not yet recruiting Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04810078Phase 3 · active not recruiting A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06863311Phase 2 · recruiting Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833085NA · not yet recruiting CAIX-targeted PET/CT in Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07688187Phase 1 · recruiting A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07828249Phase 1 · not yet recruiting Phase I Study Evaluating 161Tb-PSMA Therapy in Adult Patients With Metastatic Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06916624recruiting Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227415Phase 1/Phase 2 · recruiting Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974738Phase 1 · active not recruiting A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04977453Phase 1/Phase 2 · recruiting GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012371Phase 2 · active not recruiting Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07516366Phase 2 · recruiting Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06708949Phase 2 · active not recruiting A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06480565Phase 1/Phase 2 · active not recruiting A Phase 1/2 Trial of ADI-270 in ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07256223Phase 2 · not yet recruiting A Clinical Trial of Envafolimab Combined With Lenvatinib for Kidney Cancer With Liver Spread · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188896Phase 2 · recruiting A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06661720Phase 3 · recruiting Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793166Phase 3 · active not recruiting Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05536141Phase 1 · recruiting A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07123090Phase 2 · recruiting A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187778Phase 2 · recruiting Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776717Phase 2 · not yet recruiting TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361720Phase 2 · recruiting Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768306Phase 1 · not yet recruiting Evaluation of Safety, Pharmacokinetics, Distribution，Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 in Participants With IRM · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01038778Phase 1/Phase 2 · active not recruiting Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05706129Phase 1/Phase 2 · recruiting A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242470Phase 1 · recruiting A Study of MGC026 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187869Phase 1 · recruiting Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07615348Phase 2 · recruiting CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01575548Phase 3 · active not recruiting Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05581004Phase 1 · active not recruiting A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176483Phase 1 · recruiting Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226544Phase 2 · recruiting Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05433142Phase 1 · recruiting Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000149Phase 1 · active not recruiting A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07300241Phase 1 · recruiting Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03284385Phase 2 · active not recruiting Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2 · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06866262Phase 1/Phase 2 · recruiting Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05663710Phase 1/Phase 2 · recruiting Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179770Phase 1 · recruiting Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC) · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665361Phase 1/Phase 2 · recruiting Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07564232Phase 1 · recruiting Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07043608Phase 2 · recruiting Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942104Phase 1 · recruiting Imaging of Solid Tumors Using 18F-TRX · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049576Phase 1 · active not recruiting Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07077083Phase 2 · not yet recruiting CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07128680Phase 1 · recruiting Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04374877Phase 1 · completed Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03972657Phase 1/Phase 2 · recruiting A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339138completed Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05520099active not recruiting Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326898Phase 3 · completed Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02848768completed Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06447103Phase 2 · recruiting An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383441Phase 3 · recruiting Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07037004Phase 2 · recruiting Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026410Phase 1 · recruiting KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07510334Phase 2 · recruiting VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06783348Phase 2 · recruiting Radiopharmaceutical Treatment of Advanced Kidney Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03092856Phase 2 · active not recruiting Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02210117early Phase 1 · active not recruiting Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06090331no longer available 89Zr-DFO-girentuximab Expanded Access Program (EAP) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06949215Phase 2 · recruiting 68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07023432Phase 2 · recruiting Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602101Phase 2 · not yet recruiting Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04388852Phase 1 · active not recruiting DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06035224Phase 2 · active not recruiting Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07557225NA · recruiting 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852638Phase 2 · recruiting CD70-targeted immunoPET Imaging of Malignant Cancers · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06195150active not recruiting Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07571551Phase 2 · recruiting Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578025Phase 2 · not yet recruiting Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06708936early Phase 1 · withdrawn KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535533Phase 1/Phase 2 · completed SLM + Axitinib for Clear Cell RCC · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04053855recruiting Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04022343Phase 2 · active not recruiting Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06413680Phase 1/Phase 2 · recruiting A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06059014Phase 1/Phase 2 · completed Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03682289Phase 2 · active not recruiting Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06138496Phase 2 · completed Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03401788Phase 2 · active not recruiting A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004) · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Von Hippel Lindau Syndrome-Associated Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07197580Phase 3 · recruiting Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488572Phase 2 · enrolling by invitation Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904302Phase 2 · terminated Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469683Phase 2 · recruiting An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06349642recruiting Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07460206Phase 2 · not yet recruiting Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860386Phase 2 · suspended Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05122546Phase 1 · active not recruiting CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223541Phase 2 · recruiting Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01684397Phase 1/Phase 2 · active not recruiting Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07243067not yet recruiting Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06964958Phase 2 · active not recruiting 177LuPSMA in Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06716853Phase 1/Phase 2 · terminated A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389629Phase 2 · recruiting Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07386158Phase 2 · recruiting Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04645680Phase 2 · active not recruiting Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05239533Phase 2 · active not recruiting Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06840548Phase 1 · completed A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332923active not recruiting Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06649682Phase 1 · suspended 68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05856981Phase 1 · recruiting Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05363631Phase 1/Phase 2 · active not recruiting Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07084909Phase 2/Phase 3 · withdrawn Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03260504Phase 1 · terminated Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04989959Phase 1 · recruiting [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04779151Phase 2 · terminated Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05795595Phase 1/Phase 2 · completed A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04370509Phase 2 · terminated Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06052852Phase 1 · terminated Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05119335Phase 1/Phase 2 · terminated A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05935748Phase 2 · terminated Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218692Phase 2 · not yet recruiting RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04169711Phase 1 · completed Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03438708Phase 2 · active not recruiting Prior Axitinib as a Determinant of Outcome of Renal Surgery · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805825Phase 1 · recruiting A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04510597Phase 3 · recruiting Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06361810Phase 1/Phase 2 · withdrawn PSMA Therapy and Immunotherapy in Kidney Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07101900Phase 2 · enrolling by invitation 68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05585034Phase 1 · completed Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097935Phase 1/Phase 2 · recruiting Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04627064Phase 1 · completed ABEMA Alone or in COMBO With MK-6482 · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286294Phase 2 · active not recruiting Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04006405completed AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088134recruiting Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06976021Phase 2 · not yet recruiting Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06870279Phase 1 · not yet recruiting A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03473730early Phase 1 · completed Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06791863completed Visceral Fat Area as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Multicenter Study on Postoperative Survival · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06778538completed Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma Patients · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06775574completed Prognostic Significance of the Lung Immune Prognostic Index (LIPI) in Postoperative Clear Cell Renal Cell Carcinoma: a Multicenter Retrospective Cohort Study · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06750419Phase 3 · recruiting 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03634540Phase 2 · active not recruiting A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015740Phase 1/Phase 2 · completed Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05199272Phase 1/Phase 2 · active not recruiting A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690697Phase 2 · recruiting Combination of Toripalimab and JS004 Therapy for ccRCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06519760NA · recruiting 68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04504669Phase 1 · completed First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02819596Phase 2 · completed MEDI4736 Combinations in Metastatic Renal Cell Carcinoma · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06656039completed A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05620134Phase 1/Phase 2 · active not recruiting Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02667886Phase 1/Phase 2 · completed Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06613269Phase 2 · recruiting 68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC. · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03108066Phase 2 · completed MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06574412Phase 2 · not yet recruiting Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma. · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06559046completed A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03829111Phase 1 · completed CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06428708early Phase 1 · unknown [18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293980Phase 1 · active not recruiting A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04518046Phase 1 · completed Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399419Phase 1 · recruiting CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849118Phase 3 · completed 89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05121948Phase 1 · terminated A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06211790Phase 2 · recruiting Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05861778Phase 1 · completed Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04300140Phase 1/Phase 2 · terminated Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03680521Phase 2 · completed Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176288Phase 2 · withdrawn Avelumab, Palbociclib and Axitinib in Advanced RCC · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879471Phase 2 · unknown 68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03679767Phase 2 · completed A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879497Phase 2 · unknown 68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05879510Phase 2 · unknown 68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03280667Phase 2 · unknown Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02771626Phase 1/Phase 2 · terminated Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05728515early Phase 1 · completed A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02923531Phase 1/Phase 2 · terminated Addition of X4P-001 to Nivolumab Treatment in Participants With Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05432947NA · completed 68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00199888Phase 1 · completed Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03163667Phase 2 · completed CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC) · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440045Phase 2 · unknown A Clinical Study of 6MW3211 in Patients With Renal Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01582009Phase 1/Phase 2 · terminated Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02781506Phase 2 · terminated Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02626130early Phase 1 · completed Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01157091Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03334409Phase 2 · terminated Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05214885recruiting Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03308396Phase 1/Phase 2 · active not recruiting Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03875313Phase 1/Phase 2 · terminated Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035630Phase 2 · withdrawn Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02628535Phase 1 · terminated Safety Study of MGD009 in B7-H3-expressing Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112840Phase 1/Phase 2 · completed CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02885649early Phase 1 · terminated Enzalutamide Before Surgery in Treating Patients With Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04680416withdrawn Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors · condition mapped ALIAS · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496089Phase 1 · completed Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01896271Phase 2 · completed High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer · condition mapped CURATED_BROADER · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04995016Phase 2 · unknown Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01826877Phase 1 · completed Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04958473Phase 2 · unknown A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02118337Phase 1/Phase 2 · completed A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02581384Phase 1/Phase 2 · terminated Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors · condition mapped ONTOLOGY_EXACT · 247 trials mapped (123 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |